Back
Global Payments Vs. Spyre Therapeutics Industry Stock Comparison
Sell
20
GPN
Global Payments
Last Price:
93.89
Seasonality Move:
0.64%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
20
Global Payments (GPN)
is a Sell
Is Global Payments a Buy, Sell or Hold?
- The current Global Payments [GPN] share price is $93.89. The Score for GPN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- GPN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPN Stock Price Chart
What is Global Payments's stock price today?
-
The Global Payments share price today is $93.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
GPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.79 | Sell |
Relative Strength Index (14 RSI): | 19.36 | Sell |
Chaikin Money Flow: | 1771755 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (96.24 - 106.96) | Sell |
Bollinger Bands (100): | (108.15 - 135.29) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -1780910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.05 - 37.75) | Sell |
Bollinger Bands (100): | (27.4 - 39.18) | Sell |
GPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.83 | Sell |
20-day SMA: | 99.66 | Sell |
50-day SMA: | 110.87 | Sell |
200-day SMA: | 120.61 | Sell |
8-day EMA: | 95.74 | Sell |
20-day EMA: | 99.8 | Sell |
50-day EMA: | 108.51 | Sell |
200-day EMA: | 117.72 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.63 | Sell |
20-day SMA: | 34.16 | Sell |
50-day SMA: | 35.1 | Sell |
200-day SMA: | 24.22 | Buy |
8-day EMA: | 32.34 | Sell |
20-day EMA: | 33.91 | Sell |
50-day EMA: | 34.32 | Sell |
200-day EMA: | 27.18 | Sell |
Global Payments Earnings Growth & GPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.17 per share, an increase this year of $1.25 per share, and an increase next year of $1.57 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Global Payments Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |